Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berntorp

Showing results (71-80 of 250) with videos related to

Pageof 25
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2001
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxisS Björkman, A D Shapiro, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodiesI M Nilsson, E Berntorp, O Zettervall
Thrombosis and Haemostasis|July 1, 1993
Treatment of patients with factor VIII and IX inhibitorsI M Nilsson, E Berntorp, C Freiburghaus
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2017
Preference-based valuation of treatment attributes in haemophilia A using web surveyK Steen Carlsson, E Andersson, E Berntorp
Diabetes Research (Edinburgh, Scotland)|April 1, 1989
Transglutaminase-dependent lymphocyte transformation in type 2 diabetes mellitusK Berntorp, K F Eriksson, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 13, 2012
Quality of life in adult patients with haemophilia--a single centre experience from SwedenK Lindvall, S Von Mackensen, E Berntorp
The New England Journal of Medicine|April 14, 1988
Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIIII M Nilsson, E Berntorp, O Zettervall
Clinical Pharmacokinetics|May 1, 1992
Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studiesS Björkman, M Carlsson, E Berntorp, et al.
Thrombosis Research|December 10, 1999
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarinJ Holm, A Hillarp, L Erhardt, et al.
Pageof 25

Showing results (71-80 of 250) with videos related to

Sort By:
Pageof 25
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2001
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxisS Björkman, A D Shapiro, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Clinical trial design in haemophiliaD M Dimichele, V Blanchette, E Berntorp
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodiesI M Nilsson, E Berntorp, O Zettervall
Thrombosis and Haemostasis|July 1, 1993
Treatment of patients with factor VIII and IX inhibitorsI M Nilsson, E Berntorp, C Freiburghaus
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2017
Preference-based valuation of treatment attributes in haemophilia A using web surveyK Steen Carlsson, E Andersson, E Berntorp
Diabetes Research (Edinburgh, Scotland)|April 1, 1989
Transglutaminase-dependent lymphocyte transformation in type 2 diabetes mellitusK Berntorp, K F Eriksson, E Berntorp
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 13, 2012
Quality of life in adult patients with haemophilia--a single centre experience from SwedenK Lindvall, S Von Mackensen, E Berntorp
The New England Journal of Medicine|April 14, 1988
Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIIII M Nilsson, E Berntorp, O Zettervall
Clinical Pharmacokinetics|May 1, 1992
Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studiesS Björkman, M Carlsson, E Berntorp, et al.
Thrombosis Research|December 10, 1999
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarinJ Holm, A Hillarp, L Erhardt, et al.
Pageof 25